Insmed Inc. buy JPMorgan Chase & Co.
Start price
20.08.25
/
50%
€110.00
Target price
20.08.26
€116.07
Performance (%)
27.27%
Price
01.04.26
€142.00
Summary
This prediction is currently active. The prediction currently has a performance of 27.27%. This prediction currently runs until 20.08.26. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | 10.236% | 10.236% |
| iShares Core DAX® | 1,60 % | -7,45 % |
| iShares Nasdaq 100 | -0,73 % | -1,86 % |
| iShares Nikkei 225® | 1,30 % | -6,80 % |
| iShares S&P 500 | -0,39 % | -2,34 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Insmed Inc. diskutieren
Insmed (NASDAQ:INSM) had its price target raised by analysts at JPMorgan Chase & Co. from $111.00 to $135.00. They now have an "overweight" rating on the stock.
Ratings data for INSM provided by MarketBeat